{"gene":"DCAF6","run_date":"2026-06-09T23:54:41","timeline":{"discoveries":[{"year":2011,"finding":"NRIP/DCAF6 directly binds HPV-16 E2 protein via its N-terminal domain interacting with the E2 transactivation domain; NRIP/DCAF6 also directly binds calmodulin via its IQ domain in a calcium-dependent manner, and the NRIP–Ca2+/calmodulin complex activates the phosphatase calcineurin to dephosphorylate E2, thereby preventing E2 polyubiquitination and increasing E2 protein stability and E2-driven gene expression.","method":"Co-immunoprecipitation (in vivo and in vitro), siRNA knockdown, domain-mapping, calmodulin-binding assay, phosphatase activity assay, ubiquitination assay","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (reciprocal Co-IP in vivo and in vitro, domain truncation, enzymatic assay, ubiquitination assay, siRNA KD with functional readout) in a single focused study","pmids":["21543494"],"is_preprint":false},{"year":2015,"finding":"NRIP/DCAF6 is a Z-disc protein in skeletal muscle that acts downstream of Ca2+ signaling by binding calmodulin, thereby activating both the calcineurin–NFATc1 and CaMKII pathways; NRIP knockout mice display reduced muscle strength, fatigue susceptibility, impaired exercise adaptation, and delayed regeneration, with decreased slow-myosin gene expression, altered sarcoplasmic reticulum Ca2+ homeostasis, and reduced myogenin/desmin/embryonic MHC expression during myogenesis.","method":"NRIP-knockout mouse generation, grip-strength and fatigue testing, calmodulin co-immunoprecipitation, calcineurin/CaMKII activity assays, gene expression analysis, myotube formation assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO model with multiple orthogonal functional readouts plus biochemical pathway placement (calmodulin binding, calcineurin/CaMKII activation)","pmids":["26430214"],"is_preprint":false},{"year":2017,"finding":"NRIP/DCAF6 stabilizes the androgen receptor (AR) protein in prostate cancer by competing with DDB2 for the same AR-binding domain; NRIP/DCAF6 displaces DDB2 from the AR–DDB2–DDB1–CUL4A E3 ligase complex, preventing AR ubiquitination and degradation. Both NRIP and DDB2 bind AR but not each other via DDB1.","method":"Co-immunoprecipitation, competition binding assay, protein stability assay, IHC of prostate cancer tissues","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — reciprocal Co-IP plus competition assay and AR stability readout, single lab, two orthogonal methods","pmids":["28212551"],"is_preprint":false},{"year":2019,"finding":"NRIP/DCAF6 interacts with α-actinin 2 (ACTN2) at the Z-disc in cardiomyocytes, facilitates ACTN2-mediated F-actin bundling, and is required for binding between Z-disc proteins ACTN2 and Cap-Z; NRIP/DCAF6 deficiency causes abnormal sarcomere structure, increased mitochondrial ROS, and impaired mitochondrial respiration/ATP production via elevated NADH/NAD+ ratios, leading to reduced cardiac contractility.","method":"Muscle-specific conditional knockout (MCK-Cre::Dcaf6flox/flox), co-immunoprecipitation, confocal imaging, transmission electron microscopy, F-actin bundling assay, mitochondrial respiration assay, mitoTEMPO/nicotinic acid rescue","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse with multiple orthogonal methods (Co-IP, TEM, biochemical assays, pharmacological rescue) in a single rigorous study","pmids":["31629737"],"is_preprint":false},{"year":2021,"finding":"PPP2R1B (the PP2A scaffold subunit) is ubiquitinated and targeted for degradation by the CRL4A^DCAF6 E3 ligase complex, and is de-polyubiquitylated by USP5; mutations in PPP2R1B that confer susceptibility to CRL4A^DCAF6-mediated degradation are identified in azoospermia patients.","method":"Co-immunoprecipitation, ubiquitination assay, Ppp2r1b-knockout mice, human patient sequencing","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — ubiquitination assay plus KO mouse model plus patient mutations, single lab, multiple methods","pmids":["33913576"],"is_preprint":false},{"year":2023,"finding":"DCAF6 assembles with CUL4A, CUL4B, DDB1, and RBX1 to form a CRL4^DCAF6 E3 ubiquitin ligase that ubiquitinates and degrades the transcriptional corepressors CtBP1 and CtBP2; CtBP1/2 degradation dissociates the p300–FOXO3a complex, inducing BBC3 (PUMA) expression and caspase-dependent apoptosis. The CUL4–DDB1 inhibitor TSC01131 blocks CtBP1/2 ubiquitination and prevents apoptosis both in vitro and in a mouse IDD model.","method":"Co-immunoprecipitation, ubiquitination assay, small-molecule inhibitor (TSC01131), mouse chronic inflammation model, human IDD biopsies","journal":"Journal of molecular medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, in vitro and in vivo ubiquitination assays, pharmacological inhibition with phenotypic rescue, mouse model; multiple orthogonal methods in one study","pmids":["36688959"],"is_preprint":false}],"current_model":"DCAF6/NRIP acts as a substrate receptor (DCAF) within CRL4 (CUL4–DDB1) E3 ubiquitin ligase complexes—targeting substrates including CtBP1/2 and PPP2R1B for ubiquitination—and separately functions as a Ca2+/calmodulin-binding scaffold at the Z-disc of striated muscle, where it activates calcineurin–NFATc1 and CaMKII signaling to regulate muscle contraction, mitochondrial function, and regeneration; in the context of androgen receptor signaling, DCAF6 competes with DDB2 for AR binding within the CUL4A–DDB1 complex to stabilize AR protein."},"narrative":{"mechanistic_narrative":"DCAF6 (NRIP) is a bifunctional protein that operates both as a substrate receptor within CRL4 (CUL4–DDB1–RBX1) E3 ubiquitin ligase complexes and as a Ca2+/calmodulin-responsive scaffold in striated muscle [PMID:26430214, PMID:36688959]. As a DCAF, it assembles with CUL4A/CUL4B, DDB1, and RBX1 to direct polyubiquitination and degradation of specific substrates, including the transcriptional corepressors CtBP1 and CtBP2—whose loss dissociates the p300–FOXO3a complex to induce BBC3/PUMA and caspase-dependent apoptosis—and the PP2A scaffold subunit PPP2R1B [PMID:33913576, PMID:36688959]. In the same ligase context it can also stabilize substrates by competition: DCAF6 displaces DDB2 from the AR–DDB2–DDB1–CUL4A complex to prevent androgen receptor ubiquitination and degradation in prostate cancer [PMID:28212551]. Independently of its ligase role, DCAF6 binds calmodulin through its IQ domain in a calcium-dependent manner and acts downstream of Ca2+ signaling to activate calcineurin–NFATc1 and CaMKII pathways [PMID:21543494, PMID:26430214]. At the Z-disc of skeletal and cardiac muscle it interacts with α-actinin 2 (ACTN2), promotes ACTN2-mediated F-actin bundling and ACTN2–CapZ association, and is required for normal sarcomere structure, mitochondrial respiration, muscle strength, and regeneration [PMID:26430214, PMID:31629737]. Through calmodulin-dependent activation of calcineurin, DCAF6 dephosphorylates the HPV-16 E2 protein, blocking its polyubiquitination and stabilizing it [PMID:21543494].","teleology":[{"year":2011,"claim":"Established DCAF6/NRIP as a calcium-dependent calmodulin-binding protein that couples Ca2+ signaling to calcineurin activation and substrate stabilization, defining its scaffold/signaling arm.","evidence":"Reciprocal Co-IP in vivo and in vitro, IQ-domain mapping, calmodulin-binding and calcineurin phosphatase assays, ubiquitination assay with HPV-16 E2 as readout","pmids":["21543494"],"confidence":"High","gaps":["Demonstrated in the context of a viral substrate (E2) rather than an endogenous one","Did not connect calmodulin-binding to a ubiquitin ligase function"]},{"year":2015,"claim":"Placed DCAF6/NRIP at the muscle Z-disc and downstream of Ca2+ signaling, showing it activates calcineurin–NFATc1 and CaMKII pathways required for muscle strength, fatigue resistance, and regeneration in vivo.","evidence":"NRIP-knockout mice with grip-strength/fatigue testing, calmodulin Co-IP, calcineurin/CaMKII activity assays, myotube formation and gene expression analysis","pmids":["26430214"],"confidence":"High","gaps":["Z-disc binding partner anchoring DCAF6 not identified","Did not address any E3 ligase activity"]},{"year":2017,"claim":"Revealed DCAF6 can stabilize rather than degrade a substrate by competing with DDB2 for AR binding within the CUL4A–DDB1 complex, identifying a mechanism for AR protein stabilization in prostate cancer.","evidence":"Co-IP, competition binding assay, AR protein stability assay, IHC of prostate cancer tissues","pmids":["28212551"],"confidence":"Medium","gaps":["Single lab with two orthogonal methods","Direct ubiquitination of AR by the competing complexes not fully resolved"]},{"year":2019,"claim":"Defined the structural role of DCAF6 at the cardiac Z-disc, linking its interaction with ACTN2 and F-actin bundling to sarcomere integrity and mitochondrial respiratory function.","evidence":"Muscle-specific conditional KO (MCK-Cre::Dcaf6flox/flox), Co-IP, confocal/TEM imaging, F-actin bundling and mitochondrial respiration assays, mitoTEMPO/nicotinic acid rescue","pmids":["31629737"],"confidence":"High","gaps":["Molecular basis of the mitochondrial defect (direct vs. structural) not fully separated","ACTN2 interaction interface not mapped"]},{"year":2021,"claim":"Identified PPP2R1B as a CRL4A^DCAF6 ubiquitination substrate with USP5 as its deubiquitinase, and linked degradation-sensitizing PPP2R1B mutations to azoospermia.","evidence":"Co-IP, ubiquitination assay, Ppp2r1b-knockout mice, human patient sequencing","pmids":["33913576"],"confidence":"Medium","gaps":["Single lab","Causality between PPP2R1B degradation and the azoospermia phenotype not directly demonstrated in vivo"]},{"year":2023,"claim":"Defined the full CRL4^DCAF6 ligase composition (CUL4A/CUL4B, DDB1, RBX1) and a substrate-to-phenotype axis: CtBP1/2 degradation triggers p300–FOXO3a-dependent PUMA induction and apoptosis, druggable in an intervertebral disc degeneration model.","evidence":"Reciprocal Co-IP, in vitro and in vivo ubiquitination assays, CUL4–DDB1 inhibitor TSC01131, mouse chronic inflammation/IDD model, human IDD biopsies","pmids":["36688959"],"confidence":"High","gaps":["DCAF degron motif recognized in CtBP1/2 not defined","Regulation of substrate selection between degradative and stabilizing modes unresolved"]},{"year":null,"claim":"How DCAF6 switches between its E3 ligase substrate-receptor role and its calmodulin-scaffold/Z-disc role, and what determines whether a bound partner is degraded versus stabilized, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of substrate recognition","No unifying degron or recruitment logic across CtBP1/2, PPP2R1B, and AR","Crosstalk between calmodulin binding and ligase assembly uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[4,5]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[4,5]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,5]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,3]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,5]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[5]}],"complexes":["CRL4 (CUL4–DDB1–RBX1) E3 ubiquitin ligase","Z-disc"],"partners":["DDB1","CUL4A","CUL4B","RBX1","CALM1","ACTN2","DDB2","AR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q58WW2","full_name":"DDB1- and CUL4-associated factor 6","aliases":["Androgen receptor complex-associated protein","ARCAP","IQ motif and WD repeat-containing protein 1","Nuclear receptor interaction protein","NRIP"],"length_aa":860,"mass_kda":96.3,"function":"Ligand-dependent coactivator of nuclear receptors. Enhance transcriptional activity of the nuclear receptors NR3C1 and AR. May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q58WW2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DCAF6","classification":"Not Classified","n_dependent_lines":100,"n_total_lines":1208,"dependency_fraction":0.08278145695364239},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DDB1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DCAF6","total_profiled":1310},"omim":[{"mim_id":"610494","title":"DDB1- AND CUL4-ASSOCIATED FACTOR 6; DCAF6","url":"https://www.omim.org/entry/610494"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":585.8},{"tissue":"tongue","ntpm":429.2}],"url":"https://www.proteinatlas.org/search/DCAF6"},"hgnc":{"alias_symbol":["PC326"],"prev_symbol":["IQWD1"]},"alphafold":{"accession":"Q58WW2","domains":[{"cath_id":"2.130.10.10","chopping":"23-290_706-817","consensus_level":"high","plddt":92.7109,"start":23,"end":817}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q58WW2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q58WW2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q58WW2-F1-predicted_aligned_error_v6.png","plddt_mean":63.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DCAF6","jax_strain_url":"https://www.jax.org/strain/search?query=DCAF6"},"sequence":{"accession":"Q58WW2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q58WW2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q58WW2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q58WW2"}},"corpus_meta":[{"pmid":"26350515","id":"PMC_26350515","title":"Novel genetic causes for cerebral visual impairment.","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/26350515","citation_count":131,"is_preprint":false},{"pmid":"36926455","id":"PMC_36926455","title":"Ranking Breast Cancer Drugs and Biomarkers Identification Using Machine Learning and Pharmacogenomics.","date":"2023","source":"ACS pharmacology & translational science","url":"https://pubmed.ncbi.nlm.nih.gov/36926455","citation_count":29,"is_preprint":false},{"pmid":"28212551","id":"PMC_28212551","title":"NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28212551","citation_count":26,"is_preprint":false},{"pmid":"32668286","id":"PMC_32668286","title":"Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-Hedgehog pathway.","date":"2020","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32668286","citation_count":24,"is_preprint":false},{"pmid":"21543494","id":"PMC_21543494","title":"NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein.","date":"2011","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/21543494","citation_count":22,"is_preprint":false},{"pmid":"24222117","id":"PMC_24222117","title":"Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer.","date":"2013","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24222117","citation_count":21,"is_preprint":false},{"pmid":"1408147","id":"PMC_1408147","title":"Sequence and expression of a murine cDNA encoding PC326, a novel gene expressed in plasmacytomas but not normal plasma cells.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1408147","citation_count":18,"is_preprint":false},{"pmid":"26430214","id":"PMC_26430214","title":"NRIP is newly identified as a Z-disc protein, activating calmodulin signaling for skeletal muscle contraction and regeneration.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/26430214","citation_count":18,"is_preprint":false},{"pmid":"33913576","id":"PMC_33913576","title":"PPP2R1B is modulated by ubiquitination and is essential for spermatogenesis.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/33913576","citation_count":16,"is_preprint":false},{"pmid":"9933565","id":"PMC_9933565","title":"Physical delineation of a 700-kb region overlapping the Looptail mutation on mouse chromosome 1.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9933565","citation_count":16,"is_preprint":false},{"pmid":"28336923","id":"PMC_28336923","title":"Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28336923","citation_count":16,"is_preprint":false},{"pmid":"31629737","id":"PMC_31629737","title":"Deficiency of nuclear receptor interaction protein leads to cardiomyopathy by disrupting sarcomere structure and mitochondrial respiration.","date":"2019","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/31629737","citation_count":12,"is_preprint":false},{"pmid":"34827201","id":"PMC_34827201","title":"Comparative Genomic Characterization of Buffalo Fibronectin Type III Domain Proteins: Exploring the Novel Role of FNDC5/Irisin as a Ligand of Gonadal Receptors.","date":"2021","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/34827201","citation_count":12,"is_preprint":false},{"pmid":"1490358","id":"PMC_1490358","title":"Genes expressed selectively in plasmacytomas: markers of differentiation and transformation.","date":"1992","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1490358","citation_count":11,"is_preprint":false},{"pmid":"36688959","id":"PMC_36688959","title":"The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degeneration.","date":"2023","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36688959","citation_count":10,"is_preprint":false},{"pmid":"15168859","id":"PMC_15168859","title":"SEREX identification of the autoantibodies that are prevalent in the cerebrospinal fluid of patients with moyamoya disease.","date":"2004","source":"Biotechnology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15168859","citation_count":10,"is_preprint":false},{"pmid":"36030322","id":"PMC_36030322","title":"Cancer cell histone density links global histone acetylation, mitochondrial proteome and histone acetylase inhibitor sensitivity.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/36030322","citation_count":7,"is_preprint":false},{"pmid":"38163571","id":"PMC_38163571","title":"Identification of circular RNA-Dcaf6 as a therapeutic target for optic nerve crush-induced RGC degeneration.","date":"2023","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38163571","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10560,"output_tokens":1971,"usd":0.030623,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8900,"output_tokens":2877,"usd":0.058213,"stage2_stop_reason":"end_turn"},"total_usd":0.088836,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"NRIP/DCAF6 directly binds HPV-16 E2 protein via its N-terminal domain interacting with the E2 transactivation domain; NRIP/DCAF6 also directly binds calmodulin via its IQ domain in a calcium-dependent manner, and the NRIP–Ca2+/calmodulin complex activates the phosphatase calcineurin to dephosphorylate E2, thereby preventing E2 polyubiquitination and increasing E2 protein stability and E2-driven gene expression.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro), siRNA knockdown, domain-mapping, calmodulin-binding assay, phosphatase activity assay, ubiquitination assay\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (reciprocal Co-IP in vivo and in vitro, domain truncation, enzymatic assay, ubiquitination assay, siRNA KD with functional readout) in a single focused study\",\n      \"pmids\": [\"21543494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NRIP/DCAF6 is a Z-disc protein in skeletal muscle that acts downstream of Ca2+ signaling by binding calmodulin, thereby activating both the calcineurin–NFATc1 and CaMKII pathways; NRIP knockout mice display reduced muscle strength, fatigue susceptibility, impaired exercise adaptation, and delayed regeneration, with decreased slow-myosin gene expression, altered sarcoplasmic reticulum Ca2+ homeostasis, and reduced myogenin/desmin/embryonic MHC expression during myogenesis.\",\n      \"method\": \"NRIP-knockout mouse generation, grip-strength and fatigue testing, calmodulin co-immunoprecipitation, calcineurin/CaMKII activity assays, gene expression analysis, myotube formation assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO model with multiple orthogonal functional readouts plus biochemical pathway placement (calmodulin binding, calcineurin/CaMKII activation)\",\n      \"pmids\": [\"26430214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NRIP/DCAF6 stabilizes the androgen receptor (AR) protein in prostate cancer by competing with DDB2 for the same AR-binding domain; NRIP/DCAF6 displaces DDB2 from the AR–DDB2–DDB1–CUL4A E3 ligase complex, preventing AR ubiquitination and degradation. Both NRIP and DDB2 bind AR but not each other via DDB1.\",\n      \"method\": \"Co-immunoprecipitation, competition binding assay, protein stability assay, IHC of prostate cancer tissues\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — reciprocal Co-IP plus competition assay and AR stability readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"28212551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NRIP/DCAF6 interacts with α-actinin 2 (ACTN2) at the Z-disc in cardiomyocytes, facilitates ACTN2-mediated F-actin bundling, and is required for binding between Z-disc proteins ACTN2 and Cap-Z; NRIP/DCAF6 deficiency causes abnormal sarcomere structure, increased mitochondrial ROS, and impaired mitochondrial respiration/ATP production via elevated NADH/NAD+ ratios, leading to reduced cardiac contractility.\",\n      \"method\": \"Muscle-specific conditional knockout (MCK-Cre::Dcaf6flox/flox), co-immunoprecipitation, confocal imaging, transmission electron microscopy, F-actin bundling assay, mitochondrial respiration assay, mitoTEMPO/nicotinic acid rescue\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse with multiple orthogonal methods (Co-IP, TEM, biochemical assays, pharmacological rescue) in a single rigorous study\",\n      \"pmids\": [\"31629737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PPP2R1B (the PP2A scaffold subunit) is ubiquitinated and targeted for degradation by the CRL4A^DCAF6 E3 ligase complex, and is de-polyubiquitylated by USP5; mutations in PPP2R1B that confer susceptibility to CRL4A^DCAF6-mediated degradation are identified in azoospermia patients.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, Ppp2r1b-knockout mice, human patient sequencing\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — ubiquitination assay plus KO mouse model plus patient mutations, single lab, multiple methods\",\n      \"pmids\": [\"33913576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DCAF6 assembles with CUL4A, CUL4B, DDB1, and RBX1 to form a CRL4^DCAF6 E3 ubiquitin ligase that ubiquitinates and degrades the transcriptional corepressors CtBP1 and CtBP2; CtBP1/2 degradation dissociates the p300–FOXO3a complex, inducing BBC3 (PUMA) expression and caspase-dependent apoptosis. The CUL4–DDB1 inhibitor TSC01131 blocks CtBP1/2 ubiquitination and prevents apoptosis both in vitro and in a mouse IDD model.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, small-molecule inhibitor (TSC01131), mouse chronic inflammation model, human IDD biopsies\",\n      \"journal\": \"Journal of molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, in vitro and in vivo ubiquitination assays, pharmacological inhibition with phenotypic rescue, mouse model; multiple orthogonal methods in one study\",\n      \"pmids\": [\"36688959\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DCAF6/NRIP acts as a substrate receptor (DCAF) within CRL4 (CUL4–DDB1) E3 ubiquitin ligase complexes—targeting substrates including CtBP1/2 and PPP2R1B for ubiquitination—and separately functions as a Ca2+/calmodulin-binding scaffold at the Z-disc of striated muscle, where it activates calcineurin–NFATc1 and CaMKII signaling to regulate muscle contraction, mitochondrial function, and regeneration; in the context of androgen receptor signaling, DCAF6 competes with DDB2 for AR binding within the CUL4A–DDB1 complex to stabilize AR protein.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DCAF6 (NRIP) is a bifunctional protein that operates both as a substrate receptor within CRL4 (CUL4–DDB1–RBX1) E3 ubiquitin ligase complexes and as a Ca2+/calmodulin-responsive scaffold in striated muscle [#1, #5]. As a DCAF, it assembles with CUL4A/CUL4B, DDB1, and RBX1 to direct polyubiquitination and degradation of specific substrates, including the transcriptional corepressors CtBP1 and CtBP2—whose loss dissociates the p300–FOXO3a complex to induce BBC3/PUMA and caspase-dependent apoptosis—and the PP2A scaffold subunit PPP2R1B [#4, #5]. In the same ligase context it can also stabilize substrates by competition: DCAF6 displaces DDB2 from the AR–DDB2–DDB1–CUL4A complex to prevent androgen receptor ubiquitination and degradation in prostate cancer [#2]. Independently of its ligase role, DCAF6 binds calmodulin through its IQ domain in a calcium-dependent manner and acts downstream of Ca2+ signaling to activate calcineurin–NFATc1 and CaMKII pathways [#0, #1]. At the Z-disc of skeletal and cardiac muscle it interacts with α-actinin 2 (ACTN2), promotes ACTN2-mediated F-actin bundling and ACTN2–CapZ association, and is required for normal sarcomere structure, mitochondrial respiration, muscle strength, and regeneration [#1, #3]. Through calmodulin-dependent activation of calcineurin, DCAF6 dephosphorylates the HPV-16 E2 protein, blocking its polyubiquitination and stabilizing it [#0].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Established DCAF6/NRIP as a calcium-dependent calmodulin-binding protein that couples Ca2+ signaling to calcineurin activation and substrate stabilization, defining its scaffold/signaling arm.\",\n      \"evidence\": \"Reciprocal Co-IP in vivo and in vitro, IQ-domain mapping, calmodulin-binding and calcineurin phosphatase assays, ubiquitination assay with HPV-16 E2 as readout\",\n      \"pmids\": [\"21543494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Demonstrated in the context of a viral substrate (E2) rather than an endogenous one\", \"Did not connect calmodulin-binding to a ubiquitin ligase function\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Placed DCAF6/NRIP at the muscle Z-disc and downstream of Ca2+ signaling, showing it activates calcineurin–NFATc1 and CaMKII pathways required for muscle strength, fatigue resistance, and regeneration in vivo.\",\n      \"evidence\": \"NRIP-knockout mice with grip-strength/fatigue testing, calmodulin Co-IP, calcineurin/CaMKII activity assays, myotube formation and gene expression analysis\",\n      \"pmids\": [\"26430214\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Z-disc binding partner anchoring DCAF6 not identified\", \"Did not address any E3 ligase activity\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed DCAF6 can stabilize rather than degrade a substrate by competing with DDB2 for AR binding within the CUL4A–DDB1 complex, identifying a mechanism for AR protein stabilization in prostate cancer.\",\n      \"evidence\": \"Co-IP, competition binding assay, AR protein stability assay, IHC of prostate cancer tissues\",\n      \"pmids\": [\"28212551\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab with two orthogonal methods\", \"Direct ubiquitination of AR by the competing complexes not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the structural role of DCAF6 at the cardiac Z-disc, linking its interaction with ACTN2 and F-actin bundling to sarcomere integrity and mitochondrial respiratory function.\",\n      \"evidence\": \"Muscle-specific conditional KO (MCK-Cre::Dcaf6flox/flox), Co-IP, confocal/TEM imaging, F-actin bundling and mitochondrial respiration assays, mitoTEMPO/nicotinic acid rescue\",\n      \"pmids\": [\"31629737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the mitochondrial defect (direct vs. structural) not fully separated\", \"ACTN2 interaction interface not mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified PPP2R1B as a CRL4A^DCAF6 ubiquitination substrate with USP5 as its deubiquitinase, and linked degradation-sensitizing PPP2R1B mutations to azoospermia.\",\n      \"evidence\": \"Co-IP, ubiquitination assay, Ppp2r1b-knockout mice, human patient sequencing\",\n      \"pmids\": [\"33913576\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Causality between PPP2R1B degradation and the azoospermia phenotype not directly demonstrated in vivo\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined the full CRL4^DCAF6 ligase composition (CUL4A/CUL4B, DDB1, RBX1) and a substrate-to-phenotype axis: CtBP1/2 degradation triggers p300–FOXO3a-dependent PUMA induction and apoptosis, druggable in an intervertebral disc degeneration model.\",\n      \"evidence\": \"Reciprocal Co-IP, in vitro and in vivo ubiquitination assays, CUL4–DDB1 inhibitor TSC01131, mouse chronic inflammation/IDD model, human IDD biopsies\",\n      \"pmids\": [\"36688959\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DCAF degron motif recognized in CtBP1/2 not defined\", \"Regulation of substrate selection between degradative and stabilizing modes unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DCAF6 switches between its E3 ligase substrate-receptor role and its calmodulin-scaffold/Z-disc role, and what determines whether a bound partner is degraded versus stabilized, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of substrate recognition\", \"No unifying degron or recruitment logic across CtBP1/2, PPP2R1B, and AR\", \"Crosstalk between calmodulin binding and ligase assembly uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\"CRL4 (CUL4–DDB1–RBX1) E3 ubiquitin ligase\", \"Z-disc\"],\n    \"partners\": [\"DDB1\", \"CUL4A\", \"CUL4B\", \"RBX1\", \"CALM1\", \"ACTN2\", \"DDB2\", \"AR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}